12.4 C
New York
April 1, 2023
Coronavirus europe Germany news Vaccines and immunisation World news

Approval of new Covid jab raises hopes of persuading Germany’s unvaccinated

First doses of protein-based Nuvaxovid are expected to be used in new year after European Medicines Agency gives go-ahead

The approval of a new protein-based Covid-19 vaccine by the European Medicines Agency (EMA) has led to hopes that it could play an important role in persuading millions of Germans who have refused jabs from existing vaccines to get protection against the disease this winter.

The EMA approved the two-dose Novavax vaccine on Monday afternoon. The German government’s vaccination advisory board is expected to follow suit and allow for its use soon, a move that would be welcomed by health experts who are bracing for a huge and imminent wave of infections caused by the new Omicron variant. The first doses of Novavax are expected to be administered in Germany in the new year.

Continue reading…

Related posts

‘Chance of a lifetime’ Vermeer exhibition to open in Amsterdam

TheWorldsNews

Kefalonia claims the title of best Greek island in Which? Travel survey

TheWorldsNews

Poland ready to send tanks to Ukraine without German consent

TheWorldsNews